NovoSeven RT

Overview

Marketed

Generic name: Coagulation Factor VIIa (Recombinant)
Product class: Bypassing agent: recombinant FVIIa
Conditions: Hemophilia A or B with inhibitors; acquired hemophilia; FVII deficiency; Glanzmann thrombasthenia
Route: IV

Important safety information

Use official prescribing information and your care team for treatment decisions. This directory gives no dosing advice or medication prices.

Official product information Report a side effect to FDA

Side-effect reports go directly to the FDA, the manufacturer and your HTC. HemoLife Social never receives or stores them. In an emergency, call your local emergency number.

Member experiences

Reviews and community posts are visible only to signed-in members.

Related listings

SEVENFACT

Sources

Imported: 2026-10-26 · Individual verification pending

https://www.bleeding.org/healthcare-professionals/guidelines-on-care/products-licensed-in-the-us
https://bleedingdisordersnc.org/the-who-what-guide/
https://www.fda.gov/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/FractionatedPlasmaProducts/ucm089232.htm